Alpha DNA Investment Management’s Perficient Inc PRFT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-11,028
Closed -$1.43M 162
2021
Q4
$1.43M Buy
+11,028
New +$1.45M 0.9% 89

Other funds holding PRFT

Alpha DNA Investment Management's PRFT Position: Q1 2022 in Review

Alpha DNA Investment Management sold out of Perficient Inc (PRFT) in Q1 2022, closing a stake of 11,028 shares — an estimated $1.43M sold.

Alpha DNA Investment Management first reported a position in PRFT in Q4 2021 and held it in 1 quarter. The position peaked at $1.43M in Q4 2021. 314 funds tracked by Wall St. Rank hold PRFT as of Q1 2022.

  • Alpha DNA Investment Management reported no remaining Perficient Inc position as of Q1 2022 after selling out during the quarter.
  • Alpha DNA Investment Management sold 11,028 Perficient Inc shares in Q1 2022, an estimated $1.43M.
  • Alpha DNA Investment Management first reported a position in Perficient Inc in Q4 2021 and held it in 1 quarter.
  • Alpha DNA Investment Management's Perficient Inc position peaked at $1.43M in Q4 2021.
  • 314 funds tracked by Wall St. Rank held Perficient Inc as of Q1 2022.

Based on Alpha DNA Investment Management's 13F filing for Q1 2022, filed 13 May 2022.